UK MHRA · January 12, 2026

Guidance: Common issues identified during clinical trial applications

MHRA guidance on common validation and assessment issues in clinical trial applications and how to avoid them.

Medium impact Clinical Trials & Research UK clinical-trials

This guidance identifies common issues with validation and assessment of clinical trial applications and how to avoid them.

Read the official source ↗

Published by UK MHRA. HealthSignal links to the original document; the summary above is extracted from the source text.